Literature DB >> 3009177

Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B.

J Cohen, J S McConnell.   

Abstract

An in vitro system for studying the phenomenon of antibiotic-induced release of endotoxin from gram-negative bacteria is described. Endotoxin was measured by a quantitative limulus lysate microassay. Using a strain of Escherichia coli, ciprofloxacin was shown to cause an immediate and sustained increase in endotoxin release compared to control cultures whereas gentamicin did not, despite an equally rapid bactericidal effect. The potential value of the anti-endotoxin effect of polymyxin B was examined using a polymyxin B resistant strain of Klebsiella aerogenes. Ciprofloxacin alone caused endotoxin release, but when given with polymyxin B significantly less endotoxin was detected. These results indicate that in antibiotic-induced endotoxin release, the rate of cell death is less important than the site of antibiotic effect, and suggest that ciprofloxacin may act directly on the cell wall as well as on DNA gyrase. It is possible that polymyxin B could be used to reduce the extent of endotoxin release, and that this would be of clinical benefit.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009177     DOI: 10.1007/bf02013454

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  18 in total

1.  Liberation of endotoxin during growth of Neisseria meningitidis in a chemically-defined medium.

Authors:  B M Andersen; O Solberg
Journal:  Acta Pathol Microbiol Scand B       Date:  1978-10

2.  The complications of typhoid fever.

Authors:  H A ROWLAND
Journal:  J Trop Med Hyg       Date:  1961-06

3.  Aureomycin therapy in human brucellosis due to Brucella melitensis.

Authors:  W W SPINK; A I BRAUDE
Journal:  J Am Med Assoc       Date:  1948-12-18

4.  Prevention by polymyxin B of endotoxin lethality in mice.

Authors:  D Rifkind
Journal:  J Bacteriol       Date:  1967-04       Impact factor: 3.490

5.  Frapper fort ou frapper doucement: a gram-negative dilemma.

Authors:  D A Hopkin
Journal:  Lancet       Date:  1978-12-02       Impact factor: 79.321

6.  Jarisch-Herxheimer reaction in meningococcal meningitis.

Authors:  F E Berkowitz; P Vallabh; D I Altman; F Diamantes; H J Van Wyk; J M Stroucken
Journal:  Am J Dis Child       Date:  1983-06

Review 7.  Inhibitors of ribosome functions.

Authors:  S Pestka
Journal:  Annu Rev Microbiol       Date:  1971       Impact factor: 15.500

8.  In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

Authors:  D S Reeves; M J Bywater; H A Holt; L O White
Journal:  J Antimicrob Chemother       Date:  1984-04       Impact factor: 5.790

Review 9.  Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.

Authors:  B E Kreger; D E Craven; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

10.  Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.

Authors:  M Gellert; K Mizuuchi; M H O'Dea; T Itoh; J I Tomizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

View more
  13 in total

1.  Antibiotic-induced release of endotoxin in chronically bacteriuric patients.

Authors:  J C Hurley; W J Louis; F A Tosolini; J B Carlin
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 2.  The significance of endotoxin release in experimental and clinical sepsis in surgical patients--evidence for antibiotic-induced endotoxin release?

Authors:  R G Holzheimer
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

3.  Antibiotic-induced bacterial cell lysis: a therapeutic dilemma.

Authors:  J L Shenep
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

4.  Differential induction of pro- and anti-inflammatory cytokines in whole blood by bacteria: effects of antibiotic treatment.

Authors:  J T Frieling; J A Mulder; T Hendriks; J H Curfs; C J van der Linden; R W Sauerwein
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 5.  Antibiotic-induced release of endotoxin. A therapeutic paradox.

Authors:  J C Hurley
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

Review 6.  Clinical relevance of antibiotic-induced endotoxin release.

Authors:  J M Prins; S J van Deventer; E J Kuijper; P Speelman
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

7.  The anti-lipid A antibody HA-1A binds to rough gram-negative bacteria, fixes complement and facilitates binding to erythrocyte CR1 (CD35).

Authors:  M Tonoli; K A Davies; P J Norsworthy; J Cohen; M J Walport
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

8.  Aminoglycosides modify the in vitro metachromatic reaction and murine generalized Shwartzman phenomenon induced by Salmonella minnesota R595 lipopolysaccharide.

Authors:  A Focà; G Matera; D Iannello; M C Berlinghieri; M C Liberto
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

9.  Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis.

Authors:  Y Lin; W J Leach; W S Ammons
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 10.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.